Search research articles
Contact Us
Filters
Showing results (81-90 of 207) with videos related to
Page
of 21
Sort By:
European Urology Oncology
|
February 27, 2021
Use and Impact of Positron Emission Tomography/Computed Tomography Prior to Salvage Radiation Therapy in Men with Biochemical Recurrence After Radical Prostatectomy: A Scoping Review
Luca Valle, David Shabsovich, Gert de Meerleer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 16, 2025
FAP Expression in Renal Tumors Assessed by [<sup>68</sup>Ga]Ga-FAPI-46 PET Imaging and FAP Immunohistochemistry: A Case Series of Six Patients from the Prospective Exploratory Trial NCT04147494
Adrien Holzgreve, Lena M Unterrainer, Kimberly Flores, et al.
Clinical Nuclear Medicine
|
February 22, 2019
Prostate Cancer Pulmonary Metastasis Presenting as a Ground-Glass Pulmonary Nodule on 68Ga-PSMA-11 PET/CT
David J Lubin, Stuart B Holden, Matthew B Rettig, et al.
European Journal of Hybrid Imaging
|
October 1, 2023
Associations of quantitative whole-body PSMA-PET metrics with PSA progression status under long-term androgen deprivation therapy in prostate cancer patients: a retrospective single-center study
Vishnu Murthy, Emmanuel Appiah-Kubi, Kathleen Nguyen, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 29, 2021
<sup>68</sup>Ga-FAPI-46 and <sup>18</sup>F-FDG PET/CT in a patient with immune-related thyroiditis induced by immune checkpoint inhibitors
Masatoshi Hotta, Ida Sonni, Matthias R Benz, et al.
European Urology Focus
|
January 2, 2021
Update from PSMA-SRT Trial NCT03582774: A Randomized Phase 3 Imaging Trial of Prostate-specific Membrane Antigen Positron Emission Tomography for Salvage Radiation Therapy for Prostate Cancer Recurrence Powered for Clinical Outcome
Jeremie Calais, Wesley R Armstrong, Amar U Kishan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 3, 2017
Prostate-Specific Membrane Antigen Ligands for Imaging and Therapy
Matthias Eiber, Wolfgang P Fendler, Steven P Rowe, et al.
EJNMMI Research
|
October 30, 2023
Effects of novel androgen receptor signaling inhibitors on PSMA PET signal intensity in patients with castrate-resistant prostate cancer: a prospective exploratory serial imaging study
Ida Sonni, Andrei Gafita, Lena M Unterrainer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 11, 2017
Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for the Interpretation of PSMA-Ligand PET/CT
Matthias Eiber, Ken Herrmann, Jeremie Calais, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 23, 2025
Kinetics of PSMA PET signal after radiotherapy in prostate cancer lesions: A single-center retrospective study
Masatoshi Hotta, Kathleen Nguyen, Pan Thin, et al.
Page
of 21
Search research articles
Search
Showing results (81-90 of 207) with videos related to
Sort By:
Page
of 21
European Urology Oncology
|
February 27, 2021
Use and Impact of Positron Emission Tomography/Computed Tomography Prior to Salvage Radiation Therapy in Men with Biochemical Recurrence After Radical Prostatectomy: A Scoping Review
Luca Valle, David Shabsovich, Gert de Meerleer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 16, 2025
FAP Expression in Renal Tumors Assessed by [<sup>68</sup>Ga]Ga-FAPI-46 PET Imaging and FAP Immunohistochemistry: A Case Series of Six Patients from the Prospective Exploratory Trial NCT04147494
Adrien Holzgreve, Lena M Unterrainer, Kimberly Flores, et al.
Clinical Nuclear Medicine
|
February 22, 2019
Prostate Cancer Pulmonary Metastasis Presenting as a Ground-Glass Pulmonary Nodule on 68Ga-PSMA-11 PET/CT
David J Lubin, Stuart B Holden, Matthew B Rettig, et al.
European Journal of Hybrid Imaging
|
October 1, 2023
Associations of quantitative whole-body PSMA-PET metrics with PSA progression status under long-term androgen deprivation therapy in prostate cancer patients: a retrospective single-center study
Vishnu Murthy, Emmanuel Appiah-Kubi, Kathleen Nguyen, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 29, 2021
<sup>68</sup>Ga-FAPI-46 and <sup>18</sup>F-FDG PET/CT in a patient with immune-related thyroiditis induced by immune checkpoint inhibitors
Masatoshi Hotta, Ida Sonni, Matthias R Benz, et al.
European Urology Focus
|
January 2, 2021
Update from PSMA-SRT Trial NCT03582774: A Randomized Phase 3 Imaging Trial of Prostate-specific Membrane Antigen Positron Emission Tomography for Salvage Radiation Therapy for Prostate Cancer Recurrence Powered for Clinical Outcome
Jeremie Calais, Wesley R Armstrong, Amar U Kishan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 3, 2017
Prostate-Specific Membrane Antigen Ligands for Imaging and Therapy
Matthias Eiber, Wolfgang P Fendler, Steven P Rowe, et al.
EJNMMI Research
|
October 30, 2023
Effects of novel androgen receptor signaling inhibitors on PSMA PET signal intensity in patients with castrate-resistant prostate cancer: a prospective exploratory serial imaging study
Ida Sonni, Andrei Gafita, Lena M Unterrainer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 11, 2017
Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for the Interpretation of PSMA-Ligand PET/CT
Matthias Eiber, Ken Herrmann, Jeremie Calais, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 23, 2025
Kinetics of PSMA PET signal after radiotherapy in prostate cancer lesions: A single-center retrospective study
Masatoshi Hotta, Kathleen Nguyen, Pan Thin, et al.
Page
of 21